Propionate can act in the liver to inhibit cholesterol biosynthesis by suppressing HMG-CoA reductase activity and indeed has been shown to improve dyslipidemia and reduce atherosclerosis in obese mice [84]. This evidence concerns the gene HMGCR and atherosclerosis.